David A. Betebenner

2.4k citations

23 papers · 800 indexed · h-index 15

Molecular Biology
Organic Chemistry top 5%
Infectious Diseases top 10%
Computational Theory and Mathematics top 5%
Virology top 5%

Co-authors: Hing L. Sham Dale J. Kempf Daniel W. Norbeck Jacob J. Plattner Ayda Saldivar Norman E. Wideburg Sudthida Vasavanonda Chen Zhao
Topics: HIV/AIDS drug development and treatment (16 papers)Click Chemistry and Applications (12 papers)HIV Research and Treatment (9 papers)
Cited by: Virology Organic Chemistry Pharmaceutical Science
Journals: Biochemical and Biophysical Research Communications FEBS Letters Journal of Medicinal Chemistry
Partner nations: United States United Kingdom Hungary

In The Last Decade

David A. Betebenner

23 papers receiving 769 citations

Peers

Countries citing papers authored by David A. Betebenner

Since Specialization

Citations

This map shows the geographic impact of David A. Betebenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Betebenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Betebenner more than expected).

Fields of papers citing papers by David A. Betebenner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Betebenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Betebenner. The network helps show where David A. Betebenner may publish in the future.

Co-authorship network of co-authors of David A. Betebenner

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Betebenner. A scholar is included among the top collaborators of David A. Betebenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Betebenner. David A. Betebenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Hepatitis C virus replicon inhibitors: Synthesis and structure–activity relationships of fused pyrimidine derivatives 2012 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger,Darold L. Madigan,David W. A. Beno,David A. Betebenner,Robert J. Carrick,(unknown),Wenping He,Dachun Liu,Clarence J. Maring,Keith F. McDaniel,Hongmei Mo,Akhteruzzaman Molla,(unknown),Edward Tam,Michael D. Tufano,Dale J. Kempf	25
2	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd W. Rockway,Rong Zhang,Dachun Liu,David A. Betebenner,Keith F. McDaniel,John K. Pratt,David W. A. Beno,Debra Montgomery,(unknown),Sherie Masse,Warren M. Kati,Tim Middleton,Akhteruzzaman Molla,Clarence J. Maring,Dale J. Kempf	22
3	Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x _L from NMR and Parallel Synthesis 2005 ·Journal of Medicinal Chemistry ·Andrew M. Petros,Jürgen Dinges,David J. Augeri,(unknown),David A. Betebenner,Mark G. Bures,Steven W. Elmore,Philip J. Hajduk,Mary K. Joseph,(unknown),David G. Nettesheim,Saul H. Rosenberg,Shen Wang,Sheela A. Thomas,Xilu Wang,(unknown),Haichao Zhang,Stephen W. Fesik	229
4	Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea––synthesis and structure–activity relationships 2004 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham,David A. Betebenner,William Rosenbrook,Thomas Herrin,Ayda Saldivar,Sudthida Vasavanonda,Jacob J. Plattner,Daniel W. Norbeck	15
5	Novel Lopinavir Analogues Incorporating Non‐aromatic P‐1 Side Chains — Synthesis and Structure—Activity Relationships. 2003 ·ChemInform ·Hing L. Sham,Chen Zhao,Leping Li,David A. Betebenner,Ayda Saldivar,Sudthida Vasavanonda,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	1
6	Synthesis and structure–activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir) 2002 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham,David A. Betebenner,Xiaoqi Chen,Ayda Saldivar,Sudthida Vasavanonda,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	14
7	Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships 2002 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham,Chen Zhao,Leping Li,David A. Betebenner,Ayda Saldivar,Sudthida Vasavanonda,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	41
8	NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability 2002 ·Journal of Medicinal Chemistry ·Philip J. Hajduk,Suzanne B. Shuker,David G. Nettesheim,R.G. Craig,David J. Augeri,David A. Betebenner,Daniel H. Albert,Yan Guo,Robert Meadows,Lianhong Xu,Michael R. Michaelides,Steven K. Davidsen,Stephen W. Fesik	49
9	Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir) 2001 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham,David A. Betebenner,Thomas Herrin,Gondi Kumar,Ayda Saldivar,Sudthida Vasavanonda,Akhter Molla,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	15
10	In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification 1999 ·Drug Metabolism and Disposition ·Gondi Kumar,(unknown),Ronald Lee,David N. Whittern,John T. Uchic,Samuel Thomas,(unknown),Brian Grabowski,Hing L. Sham,David A. Betebenner,Dale J. Kempf,Jon F. Denissen	51
11	Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy 1998 ·Journal of Medicinal Chemistry ·Dale J. Kempf,Hing L. Sham,Kennan C. Marsh,Charles A. Flentge,David A. Betebenner,(unknown),Edith McDonald,Sudthida Vasavanonda,Ayda Saldivar,Norman E. Wideburg,Warren M. Kati,(unknown),Chen Zhao,(unknown),(unknown),Akhteruzzaman Molla,Jacob J. Plattner,Daniel W. Norbeck	145
12	Novel Azacyclic Ureas That Are Potent Inhibitors of HIV-1 Protease 1996 ·Biochemical and Biophysical Research Communications ·Hing L. Sham,Chen Zhao,Kennan C. Marsh,David A. Betebenner,Shuqun Lin,William Rosenbrook,Thomas Herrin,Leping Li,Darold L. Madigan,(unknown),Akhter Molla,Ayda Saldivar,Edith McDonald,Norman E. Wideburg,Dale J. Kempf,Daniel W. Norbeck,Jacob J. Plattner	6
13	Potent Inhibitors of the HIV-1 Protease with Good Oral Bioavailabilities 1995 ·Biochemical and Biophysical Research Communications ·Hing L. Sham,Chen Zhao,Kennan C. Marsh,David A. Betebenner,Shao‐Yu Lin,Edith McDonald,Sudthida Vasavanonda,Norman E. Wideburg,Ayda Saldivar,T. Robins,Dale J. Kempf,J. J. PLATTNER,Daniel W. Norbeck	6
14	Potent inhibitor of the human rhinovirus (HRV) 3C protease containing a backbone modified glutamine 1995 ·Journal of the Chemical Society Perkin Transactions 1 ·Hing L. Sham,William Rosenbrook,Warren M. Kati,David A. Betebenner,Norman E. Wideburg,Ayda Saldivar,Jacob J. Plattner,Daniel W. Norbeck	12
15	Pseudo‐symmetrical difluoroketones 1993 ·FEBS Letters ·Hing L. Sham,David A. Betebenner,Norman E. Wideburg,Ayda Saldivar,William E. Kohlbrenner,(unknown),Sudthida Vasavanonda,Dale J. Kempf,Jacob J. Clement,John E. Erickson,Jacob J. Plattner,Daniel W. Norbeck	12
16	Facile synthesis of potent HIV-1 protease inhibitors containing a novel pseudo-symmetric dipeptide isostere 1993 ·Journal of the Chemical Society Chemical Communications ·Hing L. Sham,David A. Betebenner,Chen Zhao,Norman E. Wideburg,Ayda Saldivar,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	13
17	Potent HIV-1 protease inhibitors with antiviral activities in vitro 1991 ·Biochemical and Biophysical Research Communications ·Hing L. Sham,David A. Betebenner,Norman E. Wideburg,Ayda Saldivar,William E. Kohlbrenner,Sudthida Vasavanonda,Dale J. Kempf,Daniel W. Norbeck,Chen Zhao,Jacob J. Clement,John E. Erickson,Jacob J. Plattner	17
18	Carboxymethyl-substituted bifunctional chelators: preparation of arylisothiocyanate derivatives of 3-(carboxymethyl)-3-azapentanedioic acid, 3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid, and 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid for use as protein labels 1991 ·Bioconjugate Chemistry ·S. J. KLINE,David A. Betebenner,David K. Johnson	24
19	Hepatobiliary delivery of polyaminopolycarboxylate chelates: synthesis and characterization of a cholic acid conjugate of EDTA and biodistribution and imaging studies with its indium-111 chelate 1991 ·Bioconjugate Chemistry ·David A. Betebenner,(unknown),Aline Zimmer,(unknown),Ernő Brücher,A. Dean Sherry,David K. Johnson	21
20	ChemInform Abstract: Synthesis of (2S,5S,4R)‐2,5‐Diamino‐3,3‐difluoro‐1,6‐diphenylhydroxyhexane: The Core Unit of a Potent HIV Proteinase Inhibitor. 1991 ·ChemInform ·Hing L. Sham,Norman E. Wideburg,Stephen G. Spanton,W E Kohlbrenner,David A. Betebenner,Dale J. Kempf,Daniel W. Norbeck,J. J. PLATTNER,John W. Erickson	1

About David A. Betebenner

David A. Betebenner is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 23 papers that have together received 800 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), Click Chemistry and Applications (12 papers) and HIV Research and Treatment (9 papers). The work is most often cited by research in Virology (101 citations), Organic Chemistry (348 citations) and Pharmaceutical Science (70 citations). David A. Betebenner has collaborated with scholars based in United States, United Kingdom and Hungary. Frequent co-authors include Hing L. Sham, Dale J. Kempf, Daniel W. Norbeck, Jacob J. Plattner, Ayda Saldivar, Norman E. Wideburg, Sudthida Vasavanonda, Chen Zhao, Philip J. Hajduk and David J. Augeri. Their work appears in journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact